Aqueous liquid
JP2026096220APending Publication Date: 2026-06-15SENJU PHARMA CO LTD
Patent Information
- Application Number
- JP2024209885
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2024-12-03
- Publication Date
- 2026-06-15
AI Technical Summary
Technical Problem
Existing aqueous solutions containing epinastine and/or its salts exhibit pH instability under light or heat exposure, which is not adequately addressed by conventional formulation technologies.
Method used
An aqueous solution comprising epinastine and/or its salt and monoethanolamine and/or its salt, with a pH of 7.5 or higher, which enhances pH stability against light and heat exposure.
Benefits of technology
The solution effectively suppresses pH changes due to light or heat exposure, maintaining stability within a pH range of 0.4 or less, even after exposure to high illuminance or storage at elevated temperatures.
✦ Generated by Eureka AI based on patent content.
Smart Images
Figure 2026096220000001 
Figure 2026096220000002
Abstract
The object of the present invention is to provide a liquid formulation technology relating to an aqueous liquid formulation containing epinastine and / or a salt thereof. [Solution] An aqueous solution comprising epinastine and / or a salt thereof, and monoethanolamine and / or a salt thereof, with a pH of 7.5 or higher.
Need to check novelty before this filing date? Find Prior Art
Citation Information
Patent Citations
Aqueous composition, method for improving antibacterial properties of aqueous composition, and method for producing aqueous composition
JP2023172959A
Ophthalmologic composition for allergy
JP2024072698A